Lederle Trademark Details

Lederle was registered on Tuesday, March 3, 1931 and is currently owned by American Cyanamid Company under the registration number 280833 . This mark is dead with a status of Expired. The last case file activity for this mark occured 31 years ago on Tuesday, November 3, 1992, according to the United State Patent & Trademark Office

Word Mark	Lederle
Status	Dead Registered 900 — Expired

Current Owner

American Cyanamid Company of Wayne, NJ

View all trademarks for American Cyanamid Company

Other Trademarks for American Cyanamid Company

Previous Owners

Lederle Laboratories Incorporated of New York, NY

View all trademarks for Lederle Laboratories Incorporated

Serial Number	71305932
Registration Number	280833
Status Date	Tuesday, November 3, 1992
Filing Date	Tuesday, November 3, 1992
Registration Date	Tuesday, March 3, 1931

Case File Statements

Goods & Services	Acne Vaccine, Acne Combined Vaccine, Antianthrax Serum, Antidysenteric Serum, Antigonococcus Serum, Antimeningococcus Serum, Antistreptococcus Serum, Bacillus Acidophilus Culture, Bacillis Bulgaricus Culture, Catarrhalis Combined Vaccine, Catarrhalis Ingluenza Vaccine, Cholera Vaccine, Colon Vaccine, Combined Bacterial Vaccine (Vancott), Corpus Luteum Extract (Ampul), Diphtheria Antitoxin, Diphtheria Toxin Antitoxin Mixture, Diphtheria Toxin Antitoxin Mixture (Goat), Schick Test; Schick Test, Control; Epinephrine Hydrochloride; Erysipelasantitoxin, Gonococcus Vaccine, Gonococcus Combined Vaccine, Influenza Combined Vaccine, Normal Horse Serum, Normal Saline Solution, Pertussis Glycerol Vaccine, Pertussis Vaccine, Pertussis Combined Vaccine, Plague Vaccine (Bubonic) Pneumococcus Vaccine I, II, and III; Pneumococcus Combined Vaccine, Rabies Vaccine (14doses) (Semple Method), Staphylococcus Vaccine, Staphylococcus Aureus Vaccine, Staphylococcus Combined Vaccine, Staphylococcus-Streptococcus Vaccine, Streptococcu

Acne Vaccine, Acne Combined Vaccine, Antianthrax Serum, Antidysenteric Serum, Antigonococcus Serum, Antimeningococcus Serum, Antistreptococcus Serum, Bacillus Acidophilus Culture, Bacillis Bulgaricus Culture, Catarrhalis Combined Vaccine, Catarrhalis Ingluenza Vaccine, Cholera Vaccine, Colon Vaccine, Combined Bacterial Vaccine (Vancott), Corpus Luteum Extract (Ampul), Diphtheria Antitoxin, Diphtheria Toxin Antitoxin Mixture, Diphtheria Toxin Antitoxin Mixture (Goat), Schick Test; Schick Test, Control; Epinephrine Hydrochloride; Erysipelasantitoxin, Gonococcus Vaccine, Gonococcus Combined Vaccine, Influenza Combined Vaccine, Normal Horse Serum, Normal Saline Solution, Pertussis Glycerol Vaccine, Pertussis Vaccine, Pertussis Combined Vaccine, Plague Vaccine (Bubonic) Pneumococcus Vaccine I, II, and III; Pneumococcus Combined Vaccine, Rabies Vaccine (14doses) (Semple Method), Staphylococcus Vaccine, Staphylococcus Aureus Vaccine, Staphylococcus Combined Vaccine, Staphylococcus-Streptococcus Vaccine, Streptococcu

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	018
Status	9 — Expired
Status Date	Tuesday, November 3, 1992
First Use Anywhere	Monday, January 1, 1906
First Use In Commerce	Monday, January 1, 1906
Primary Code	018

Trademark Timeline

Jan 01 1906

First use anywhere for the mark
Jan 01 1906

First use in commerce for the mark
Sep 22 1930

Trademark application filed with USPTO
Mar 03 1931

Trademark officially registered with the USPTO
Mar 03 1971

Registered and Renewed (second Renewal - 20 Yrs)
Nov 03 1992

Expired Sec. 9